Oral semaglutide (Rybelsus) can now be used to reduce major adverse cardiovascular events in patients with type 2 diabetes and high cardiovascular risk, following the US Food and Drug Administration’s ...
Red blood cell distribution width coefficient of variation may be a useful clinical biomarker for detecting tubular injury in patients with type 2 diabetes. Red blood cell distribution width ...